Cancer is a comprehensive classification encompassing more than 100 forms of
malignancies that manifest in diverse tissues within the human body. Recent studies have …

Pituitary adenoma (PA) accounts for 10–15% of all intracranial neoplasms. Even though
most pituitary adenomas are benign, it is known that almost 35% of them exhibit an …

Background Circular RNA nuclear factor IX (circNFIX) has been reported to play an
important role in glioma progression. However, the mechanism by which circNFIX …

Glioblastoma (GBM) is the commonest form of primary brain tumor in the central nervous
system, with median survival below 15 months and only a 25% two-year survival rate for …

Glioma, particularly its most malignant form, glioblastoma multiforme (GBM), is the most
common and aggressive malignant central nervous system tumor. The drawbacks of the …

Abstract Heptapeptide ATWLPPR (A7R) binds specifically to vascular endothelial growth
factor receptor 2 (VEGFR2) and neuropilin-1 (NRP-1) overexpressed in glioma cells …

Xanthatin is a natural sesquiterpene lactone purified from Xanthium strumarium L., which
has shown prominent antitumor activity against a variety of cancer cells. In the current study …

Because of the characteristics of high invasiveness, relapse, and poor prognosis, the
management of malignant gliomas has always been a great challenge. Nod-like receptor …

Glioma is the most common and aggressive primary brain tumor in adults with high morbidity
and mortality. Rapid proliferation and diffuse migration are the main obstacles to successful …

Abstract Background Circular RNAs (circRNAs) are related to the carcinogenesis of cancers,
including glioma. However, the role and mechanism of circRNA pleiotrophin (circ-PTN) …